205 related articles for article (PubMed ID: 26967304)
21. Retreatment rates for uncomplicated gonorrhea infection: comparing ceftriaxone and azithromycin versus ceftriaxone and doxycycline.
Schumacher CM; Ghanem KG
Sex Transm Dis; 2013 Jul; 40(7):539-45. PubMed ID: 23965767
[TBL] [Abstract][Full Text] [Related]
22. Gentamicin Alone Is Inadequate to Eradicate Neisseria Gonorrhoeae From the Pharynx.
Barbee LA; Soge OO; Morgan J; Leclair A; Bass T; Werth BJ; Hughes JP; Golden MR
Clin Infect Dis; 2020 Nov; 71(8):1877-1882. PubMed ID: 31712813
[TBL] [Abstract][Full Text] [Related]
23. Frequency of Nucleic Acid Amplification Test Positivity Among Men Who Have Sex With Men Returning for a Test-of-Cure Visit 7 to 30 Days After Treatment of Laboratory-Confirmed Neisseria gonorrhoeae Infection at 2 Public Sexual Health Clinics, New York City, 2013 to 2016.
Okah E; Westheimer EF; Jamison K; Schillinger JA
Sex Transm Dis; 2018 Mar; 45(3):177-182. PubMed ID: 29420445
[TBL] [Abstract][Full Text] [Related]
24. Cephalosporin and azithromycin susceptibility in Neisseria gonorrhoeae isolates by site of infection, British Columbia, 2006 to 2011.
Hottes TS; Lester RT; Hoang LM; McKay R; Imperial M; Gilbert M; Patrick D; Wong T; Martin I; Ogilvie G
Sex Transm Dis; 2013 Jan; 40(1):46-51. PubMed ID: 23250301
[TBL] [Abstract][Full Text] [Related]
25. ACOG Committee Opinion No. 645: Dual Therapy for Gonococcal Infections.
Committee on Gynecologic Practice
Obstet Gynecol; 2015 Nov; 126(5):e95-9. PubMed ID: 26488526
[TBL] [Abstract][Full Text] [Related]
26. ACOG Committee Opinion No. 645 Summary: Dual Therapy for Gonococcal Infections.
Committee on Gynecologic Practice
Obstet Gynecol; 2015 Nov; 126(5):1126. PubMed ID: 26488518
[TBL] [Abstract][Full Text] [Related]
27. First cases of Neisseria gonorrhoeae resistant to ceftriaxone in Catalonia, Spain, May 2011.
Carnicer-Pont D; Smithson A; Fina-Homar E; Bastida MT;
Enferm Infecc Microbiol Clin; 2012 Apr; 30(4):218-9. PubMed ID: 22244992
[No Abstract] [Full Text] [Related]
28. Committee Opinion No. 645 Summary: Dual Therapy for Gonococcal Infections.
Obstet Gynecol; 2016 May; 127(5):1126. PubMed ID: 27548417
[TBL] [Abstract][Full Text] [Related]
29. Efficacy and Safety of Single-Dose Oral Delafloxacin Compared With Intramuscular Ceftriaxone for Uncomplicated Gonorrhea Treatment: An Open-Label, Noninferiority, Phase 3, Multicenter, Randomized Study.
Hook EW; Golden MR; Taylor SN; Henry E; Tseng C; Workowski KA; Swerdlow J; Nenninger A; Cammarata S
Sex Transm Dis; 2019 May; 46(5):279-286. PubMed ID: 30985632
[TBL] [Abstract][Full Text] [Related]
30. Treatment failure of pharyngeal gonorrhoea with internationally recommended first-line ceftriaxone verified in Slovenia, September 2011.
Unemo M; Golparian D; Potočnik M; Jeverica S
Euro Surveill; 2012 Jun; 17(25):. PubMed ID: 22748003
[TBL] [Abstract][Full Text] [Related]
31. Challenges in implementing the new BASHH guidelines for the management of gonorrhoea.
Rodgers S; Murgatroyd M; Perez K; Kingston M; Lee V
Int J STD AIDS; 2014 Feb; 25(2):145-7. PubMed ID: 23970641
[TBL] [Abstract][Full Text] [Related]
32. Neisseria gonorrhoeae with reduced susceptibility to azithromycin--San Diego County, California, 2009.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2011 May; 60(18):579-81. PubMed ID: 21566558
[TBL] [Abstract][Full Text] [Related]
33. Trends of sexually transmitted diseases and antimicrobial resistance in Neisseria gonorrhoeae.
Matsumoto T
Int J Antimicrob Agents; 2008 Feb; 31 Suppl 1():S35-9. PubMed ID: 18164598
[TBL] [Abstract][Full Text] [Related]
34. Failure of Dual Antimicrobial Therapy in Treatment of Gonorrhea.
Fifer H; Natarajan U; Jones L; Alexander S; Hughes G; Golparian D; Unemo M
N Engl J Med; 2016 Jun; 374(25):2504-6. PubMed ID: 27332921
[No Abstract] [Full Text] [Related]
35. Update to CDC's Sexually transmitted diseases treatment guidelines, 2010: oral cephalosporins no longer a recommended treatment for gonococcal infections.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2012 Aug; 61(31):590-4. PubMed ID: 22874837
[TBL] [Abstract][Full Text] [Related]
36. Evaluation of treatment with single-dose ampicillin/sulbactam with probenecid or ceftriaxone in patients with uncomplicated gonorrhea.
Baddour LM; Busby L; Shapiro E; Cox KB; Glassco S; Johnson JK
Sex Transm Dis; 1992; 19(6):341-5. PubMed ID: 1492262
[TBL] [Abstract][Full Text] [Related]
37. Spontaneous Clearance of Pharyngeal Gonococcal Infections: A Retrospective Study in Patients of the Sexually Transmitted Infections Clinic; Amsterdam, the Netherlands; 2012 to 2015.
Hananta IPY; de Vries HJC; van Dam AP; van Rooijen MS; Soebono H; Schim van der Loeff MF
Sex Transm Dis; 2018 Sep; 45(9):594-599. PubMed ID: 29465642
[TBL] [Abstract][Full Text] [Related]
38. CDC update on gonorrhea: expand treatment to limit resistance.
Campos-Outcalt D
J Fam Pract; 2011 Dec; 60(12):736-40. PubMed ID: 22163356
[No Abstract] [Full Text] [Related]
39. Two cases of multidrug-resistant
Poncin T; Merimeche M; Braille A; Mainardis M; Bebear C; Jacquier H; Berçot B
Euro Surveill; 2019 Sep; 24(36):. PubMed ID: 31507264
[TBL] [Abstract][Full Text] [Related]
40. Phenotypic and genetic characterization of the first two cases of extended-spectrum-cephalosporin-resistant Neisseria gonorrhoeae infection in South Africa and association with cefixime treatment failure.
Lewis DA; Sriruttan C; Müller EE; Golparian D; Gumede L; Fick D; de Wet J; Maseko V; Coetzee J; Unemo M
J Antimicrob Chemother; 2013 Jun; 68(6):1267-70. PubMed ID: 23416957
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
